Ignite Creation Date:
2024-05-06 @ 7:39 PM
Last Modification Date:
2024-10-26 @ 3:11 PM
Study NCT ID:
NCT06088290
Status:
RECRUITING
Last Update Posted:
2024-06-27
First Post:
2023-09-28
Brief Title:
Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma
Sponsor:
PharmaMar
Organization:
PharmaMar
Organization Data
Organization:
PharmaMar
Class:
INDUSTRY
Study ID:
PM1183-C-010-22
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
PharmaMar
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None